Comparison of                          68                         Ga-PSMA-11 and                          18                         F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence: Prospective trial is on its way

Jeremie Calais; Wolfgang Peter Fendler; Ken Herrmann; Matthias Eiber; Francesco Ceci

doi:10.2967/jnumed.118.209965

Comparison of ⁶⁸ Ga-PSMA-11 and ¹⁸ F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence: Prospective trial is on its way

Jeremie Calais
, Wolfgang Peter Fendler
, Ken Herrmann
, Matthias Eiber
, Francesco Ceci

David Geffen School of Medicine at UCLA

Publikation: Beitrag in Fachzeitschrift › Brief › Begutachtung

4 Zitate (Scopus)

Originalsprache	Englisch
Seiten (von - bis)	861
Seitenumfang	1
Fachzeitschrift	Journal of Nuclear Medicine
Jahrgang	59
Ausgabenummer	5
DOIs	https://doi.org/10.2967/jnumed.118.209965
Publikationsstatus	Veröffentlicht - 1 Mai 2018
Extern publiziert	Ja

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Zugriff auf Dokument

10.2967/jnumed.118.209965

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

Calais, J., Fendler, W. P., Herrmann, K., Eiber, M., & Ceci, F. (2018). Comparison of ⁶⁸ Ga-PSMA-11 and ¹⁸ F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence: Prospective trial is on its way. Journal of Nuclear Medicine, 59(5), 861. https://doi.org/10.2967/jnumed.118.209965

Calais, Jeremie ; Fendler, Wolfgang Peter ; Herrmann, Ken et al. / Comparison of ⁶⁸ Ga-PSMA-11 and ¹⁸ F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence : Prospective trial is on its way. in: Journal of Nuclear Medicine. 2018 ; Jahrgang 59, Nr. 5. S. 861.

@article{616c4abb04ec4efd8d2a45870543dc0f,

title = "Comparison of 68 Ga-PSMA-11 and 18 F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence: Prospective trial is on its way",

author = "Jeremie Calais and Fendler, \{Wolfgang Peter\} and Ken Herrmann and Matthias Eiber and Francesco Ceci",

year = "2018",

month = may,

day = "1",

doi = "10.2967/jnumed.118.209965",

language = "English",

volume = "59",

pages = "861",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine Inc.",

number = "5",

}

Calais, J, Fendler, WP, Herrmann, K, Eiber, M & Ceci, F 2018, 'Comparison of ⁶⁸ Ga-PSMA-11 and ¹⁸ F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence: Prospective trial is on its way', Journal of Nuclear Medicine, Jg. 59, Nr. 5, S. 861. https://doi.org/10.2967/jnumed.118.209965

Comparison of ⁶⁸ Ga-PSMA-11 and ¹⁸ F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence: Prospective trial is on its way. / Calais, Jeremie; Fendler, Wolfgang Peter; Herrmann, Ken et al.
in: Journal of Nuclear Medicine, Jahrgang 59, Nr. 5, 01.05.2018, S. 861.

Publikation: Beitrag in Fachzeitschrift › Brief › Begutachtung

TY - JOUR

T1 - Comparison of 68 Ga-PSMA-11 and 18 F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence

T2 - Prospective trial is on its way

AU - Calais, Jeremie

AU - Fendler, Wolfgang Peter

AU - Herrmann, Ken

AU - Eiber, Matthias

AU - Ceci, Francesco

PY - 2018/5/1

Y1 - 2018/5/1

UR - https://www.scopus.com/pages/publications/85046395569

U2 - 10.2967/jnumed.118.209965

DO - 10.2967/jnumed.118.209965

M3 - Letter

C2 - 29496985

AN - SCOPUS:85046395569

SN - 0161-5505

VL - 59

SP - 861

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

IS - 5

ER -

Calais J, Fendler WP, Herrmann K, Eiber M, Ceci F. Comparison of ⁶⁸ Ga-PSMA-11 and ¹⁸ F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrence: Prospective trial is on its way. Journal of Nuclear Medicine. 2018 Mai 1;59(5):861. doi: 10.2967/jnumed.118.209965